Uncovering interleukin-7 in celiac disease through a human autoimmune organoid model: A commentary

Abstract

This commentary describes an innovative air-liquid interface (ALI) duodenal organoid system for studying celiac disease (CeD). Derived from patient biopsies, this model uniquely preserves the native tissue microenvironment, including epithelial, stromal, and diverse tissue-resident immune cells, overcoming the limitations of conventional cultures and animal models. When stimulated with gluten peptides, the organoids replicate key pathological features of CeD, such as epithelial cell death mediated by cytotoxic T cells. Research has identified interleukin-7 (IL-7), secreted by mesenchymal cells, as a critical and previously underappreciated mediator of this gluten-induced autoimmune attack. This discovery highlights IL-7 as a promising therapeutic target and establishes the ALI organoid platform as a powerful tool for investigating complex epithelial-immune interactions in other autoimmune and infectious diseases, drug screening, and personalized medicine.

Keywords

Organoids / Celiac disease / Immune-epithelial interactions / Interleukin-7 / Therapeutic targeting

Acknowledgments

None.

Funding

None.

Conflict of interest

The authors declare they have no competing interests.

Author contributions

Conceptualization: Zhihang Zhou, Jing Xie

Visualization: Enling Hu

Writing-original draft: Enling Hu, Ruiqi Xie

Writing-review & editing: Ruiqi Xie

Ethics approval and consent to participate

Not applicable.

Consent for publication

Not applicable.

Availability of data

Not applicable.

References

[1] Hofer M, Lutolf MP. Engineering organoids. Nat Rev Mater. 2021; 6(5):402-420. doi: 10.1038/s41578-021-00279-y

[2] Makharia GK, Singh P, Catassi C, et al. The global burden of coeliac disease: Opportunities and challenges. Nat Rev Gastroenterol Hepatol. 2022; 19(5):313-327. doi: 10.1038/s41575-021-00552-z

[3] Freire R, Ingano L, Serena G, et al. Human gut derived-organoids provide model to study gluten response and effects of microbiota-derived molecules in celiac disease. Sci Rep. 2019; 9(1):7029. doi: 10.1038/s41598-019-43426-w

[4] Santos AJM, van Unen V, Lin Z, et al. A human autoimmune organoid model reveals IL-7 function in coeliac disease. Nature. 2024; 632(8024):401-410. doi: 10.1038/s41586-024-07716-2

[5] Calzascia T, Pellegrini M, Lin A, et al. CD4 T cells, lymphopenia, and IL-7 in a multistep pathway to autoimmunity. Proc Natl Acad Sci U S A. 2008; 105:2999-3004. doi: 10.1073/pnas.0712135105

[6] Fleck JS, Jansen SMJ, Wollny D, et al. Inferring and perturbing cell fate regulomes in human brain organoids. Nature. 2023; 621(7978):365-372. doi: 10.1038/s41586-022-05279-8

[7] Lorenzo-Martín LF, Hübscher T, Bowler AD, et al. Spatiotemporally resolved colorectal oncogenesis in mini-colons ex vivo. Nature. 2024; 629(8011):450-457. doi: 10.1038/s41586-024-07330-2

[8] Bender E. How organoids are advancing the understanding of chronic kidney disease. Nature. 2023; 615(7951):S10-S11. doi: 10.1038/d41586-023-00652-7

[9] Means JC, Martinez-Bengochea AL, Louiselle DA, et al. Rapid and scalable personalized ASO screening in patient-derived organoids. Nature. 2025; 638(8049):237-243. doi: 10.1038/s41586-024-08462-1